Skip to main content

Table 1 Levels of estradiol and estrone in patients with diffuse cutaneous systemic sclerosis and healthy controls

From: Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis

  Low Intermediate High Total
Estradiola     
   Controls 14 20 1 35
   dcSSc 34 24 10 68
   Total 48 44 11 103
Estroneb     
   Controls 7 18 0 25
   dcSSc 9 31 15 55
   Total 16 49 15 80
  1. aLow (<5 pg/ml), intermediate (5 to 10 pg/ml), and high (>10 pg/ml); P = 0.04 for controls versus diffuse cutaneous systemic sclerosis (dcSSc) using chi-square/Fisher's exact test. bLow (<15 pg/ml), intermediate (15 to 75 pg/ml), and high (>75 pg/ml); P = 0.006 for controls versus dcSSc using chi-square/Fisher's exact test.